Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 29;7(6):477-482.
doi: 10.1177/24741264231200739. eCollection 2023 Nov-Dec.

Clinical Outcome of Cystoid Macular Edema in Silicone Oil-Filled Eyes

Abdulla Shaheen  1 , James Lai  1 , Maria Magraner  1 , Noy Ashkenazy  2 , Harry W Flynn Jr  1 , Jayanth Sridhar  1 , Nicolas A Yannuzzi  1
Affiliations

Clinical Outcome of Cystoid Macular Edema in Silicone Oil-Filled Eyes

Abdulla Shaheen et al. J Vitreoretin Dis. .

Abstract

Purpose: To investigate the clinical outcome of cystoid macular edema (CME) in eyes undergoing silicone oil (SO) tamponade with subsequent SO removal (SOR). Methods: A retrospective case series of adult patients with CME treated with SO tamponade and SOR was conducted between January 2015 and January 2021. Exclusion criteria included eyes with a prior SO tamponade, those that did not undergo SOR, or those with infectious/inflammatory diagnoses. The primary outcomes were the incidence and resolution rates of CME in eyes with SO tamponade that had undergone SOR. The secondary outcomes included changes in best-corrected visual acuity (BCVA) and central field thickness (CFT). Results: Nineteen eyes of 19 patients (58% men) aged 52 years (interquartile range [IQR], 45-66 years) met the study inclusion criteria. The median (IQR) follow-up duration post SOR was 22 (8-35) months. The mean CFT decline for the CME-resolved cases was 13.1 µm/mo (P = .257). CME resolved in only 10 eyes (53%), 7 (67%) of which occurred after SOR. The median (IQR) BCVA was 20/400 (20/200 to 20/1262) at CME diagnosis and 20/796 (20/252 to hand motions) after SOR, with 0.184 worsening in logMAR BCVA (P = .340). Medical treatment was not associated with CME resolution compared with observation (50% vs 89%, respectively; P = .069). Eyes with proliferative vitreoretinopathy (PVR) had a higher rate of persistent CME compared with eyes with other diagnoses (78% vs 10%, respectively; P = .005). Conclusions: Nearly half had nonresolution of CME after SO was removed. The VA at the last follow-up was unaffected by CME resolution. Preoperative PVR may be a risk factor for unresolved CME.

Keywords: cystoid macular edema; pars plana vitrectomy; proliferative vitreoretinopathy; retinal detachment; silicone oil; visual acuity.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

    1. Gebler M, Pfeiffer S, Callizo J, Hoerauf H, Feltgen N, Bemme S. Incidence and risk factors for macular oedema after primary rhegmatogenous retinal detachment surgery: a prospective single-centre study. Acta Ophthalmol. 2022;100(3):295-301. - PubMed
    1. Yang JY, Kim HK, Kim SH, Kim SS. Incidence and risk factors of cystoid macular edema after vitrectomy with silicone oil tamponade for retinal detachment. Korean J Ophthalmol. 2018;32(3):204-210. - PMC - PubMed
    1. Sabates NR, Sabates FN, Sabates R, Lee KY, Ziemianski MC. Macular changes after retinal detachment surgery. Am J Ophthalmol. 1989;108(1):22-29. - PubMed
    1. Meredith TA, Reeser FH, Topping TM, Aaberg TM. Cystoid macular edema after retinal detachment surgery. Ophthalmology. 1980;87(11):1090-1095. - PubMed
    1. Delolme MP, Dugas B, Nicot F, Muselier A, Bron AM, Creuzot-Garcher C. Anatomical and functional macular changes after rhegmatogenous retinal detachment with macula off. Am J Ophthalmol. 2012;153(1):128-136. - PubMed